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Outcomes of Telehealth in the Management of Type 2 Diabetes—A 
Systematic Review and Meta‑analysis of Randomised Controlled 
Trials
NISHA NANGRANI, USMAN MALABU, VENKAT VANGAVETI, Townsville, Austra-
lia, Douglas, Australia
Background: The outcomes of telehealth in the management of type 2 
diabetes (T2DM) have not been evaluated since the publication of recent 
clinical trials.
Objective: To conduct a systematic review and meta-analysis of recently 
published randomized controlled trials (RCTs) to assess the biochemical, 
clinical and psychosocial outcomes of telehealth in subjects with T2DM.
Methods: Electronic databases, MEDLINE, CINAHL, INFORMIT, SCOPUS 
and the Cochrane Central Register of Controlled Trials and reference lists 
of existing systematic reviews were searched until August 2017 to identify 
relevant studies. Study search and selection were performed by two inde-
pendent reviewers. 4791 articles were retrieved of which 11 RCTs (n=3772) 
were included. A meta-analysis with random effects model was applied to 
estimate the pooled results.
Results: Telehealth was associated with a statistically significant and 
clinically relevant absolute decline in glycosylated haemoglobin (HbA1c) 
compared to usual care (mean difference -0.17%; 95% CI -0.25 to -0.09%; 
p<0.0001), especially if participants had a mean baseline HbA1c≥8.0%; 
were less than sixty years of age or received telehealth for less than one 
year. There was no clinically significant reduction in LDL-cholesterol (LDL-c), 
body mass index (BMI), systolic (SBP) or diastolic blood pressure (DBP).
Conclusion: Telehealth interventions were associated with improved 
glycaemic control (HbA1c) in T2DM diabetic patients. However, no clinically 
relevant impact was observed on lipid profile, blood pressure, body mass 
index and psychosocial well-being. Future studies should seek to evaluate 
the effect of intervention duration on HbA1c, psychosocial outcomes and the 
effectiveness of telehealth in rural and underserved populations.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
